Happy New Year! We hope you had a wonderful holiday season and remain grateful for your ongoing support for our work. The Melanoma Research Alliance begins 2015 with enormous optimism and an undeterred focus on defeating melanoma. The landmark progress and achievements of 2014 have re-energized our work to find and fund better outcomes for patients and ultimately cures for this deadly disease.
In 2014, MRA awarded a record-breaking $11.4 million in grants, was named the #1 Grant-Giving Disease Foundation by Genetic Engineering & Biotechnology News (GEN), and played important leadership roles in accelerating the progress that has brought eight new treatments for melanoma available in the U.S. since MRA's launch. We also celebrated the selection of MRA Board Member and Chair of the Scientific Advisory Panel, Dr. Suzanne Topalian, as one of the journal Nature's "Ten People Who Mattered This Year" for her pioneering work in the field of immunotherapy.
We are continuing our efforts to direct critical resources toward funding the most innovative translational melanoma research. Our world-class Grant Review Committee has begun evaluating submissions in response to the 2014-2015 Request for Proposals, and planning for MRA's upcoming 7th Annual Scientific Retreat is charging full speed ahead.
With the treatment landscape for patients evolving so quickly as a result of the field's scientific progress, MRA has launched an enhanced patient engagement program. We are pleased to share these videos featuring leading experts in the melanoma field:
Full video coverage of the MRA-GRACE Immunotherapy Patient Forum for Melanoma, Kidney and Lung Cancers held on October 26, 2014 in Chicago.
The first in a series of webinars, "Melanoma 101: A Brighter Outlook," with Dr. David Fisher from Massachusetts General Hospital, produced with the Melanoma International Foundation.
Stay tuned for the next webinar installment, "Surgical Treatments for Melanoma," with Dr. Jeffrey Gershenwald from M.D. Anderson Cancer Center.
Wishing you all the best for a healthy, happy and productive 2015.
Wendy K.D. Selig
President and CEO
MELANOMA RESEARCH ALLIANCE FOUNDATION (Melanoma Research Alliance; MRA) is a GuideStar Exchange Gold Participant Want to learn more about the GuideStar Exchange?
Click here »